Loading insider details...
Latest Form 4 (Aug 5, 2026): Sale of 38,800 FATE shares, $95.4K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 5, 2026 | FATE THERAPEUTICS INC (FATE) | Sale | 38,800 | $95.4K |
| May 21, 2026 | FATE THERAPEUTICS INC (FATE) | Sale | 25,590 | $48.1K |
| May 7, 2026 | FATE THERAPEUTICS INC (FATE) | Exercise/Conversion | 122,220 | $161.3K |
| Jan 16, 2026 | FATE THERAPEUTICS INC (FATE) | Grant/Award | 100,000 | n/a |
| Jan 12, 2026 | FATE THERAPEUTICS INC (FATE) | Sale | 10,589 | $11.3K |
| Aug 5, 2025 | FATE THERAPEUTICS INC (FATE) | Sale | 9,037 | $9.6K |
| Jan 16, 2025 | FATE THERAPEUTICS INC (FATE) | Grant/Award | 70,000 | n/a |
| Jan 13, 2025 | FATE THERAPEUTICS INC (FATE) | Sale | 5,654 | $8.8K |
| Jul 31, 2024 | FATE THERAPEUTICS INC (FATE) | Grant/Award | 200,000 | n/a |
| Feb 2, 2024 | FATE THERAPEUTICS INC (FATE) | Grant/Award | 425,000 | n/a |